Xylem Aktie
116,00
EUR
+0,80
EUR
+0,69
%
119,65
USD
+0,67
USD
+0,56
%
Werbung
Xylem Aktie Analyse
| 19.12.18 | Xylem Buy | Stifel, Nicolaus & Co., Inc. | |
| 04.08.17 | Xylem Outperform | BMO Capital Markets | |
| 02.08.17 | Xylem Outperform | RBC Capital Markets | |
| 23.06.17 | Xylem Outperform | BMO Capital Markets | |
| 15.05.17 | Xylem overweight | Barclays Capital | |
| 03.02.17 | Xylem Outperform | Boenning & Scattergood | |
| 03.02.17 | Xylem Outperform | RBC Capital Markets | |
| 02.11.16 | Xylem Hold | Stifel, Nicolaus & Co., Inc. | |
|
Werbung
|
|||
| 21.03.16 | Xylem Hold | Stifel, Nicolaus & Co., Inc. | |
| 06.01.16 | Xylem Outperform | RBC Capital Markets | |
| 28.09.15 | Xylem Outperform | Oppenheimer & Co. Inc. | |
| 03.09.15 | Xylem Buy | Stifel, Nicolaus & Co., Inc. | |
| 08.07.15 | Xylem Accumulate | Global Hunter Securities | |
| 15.06.15 | Xylem Outperform | Oppenheimer & Co. Inc. | |
| 01.04.15 | Xylem Outperform | Boenning & Scattergood | |
| 05.01.15 | Xylem Hold | Stifel, Nicolaus & Co., Inc. | |
| 29.10.14 | Xylem overweight | Barclays Capital | |
| 14.12.12 | Xylem kaufen | Fuchsbriefe | |
Werbung